Correction of rat acute cholangitis using water-soluble C60 fullerene nanoparticles

Authors

  • H.M. Kuznietsova Institute of Biology and Medicine, Taras Shevchenko National University of Kiev
  • N.V. Dziubenko Institute of Biology and Medicine, Taras Shevchenko National University of Kiev
  • T.V. Rybalchenko Institute of Biology and Medicine, Taras Shevchenko National University of Kiev
  • O.V. Ogloblya Institute of Biology and Medicine, Taras Shevchenko National University of Kiev
  • V.K. Rybalchenko Institute of Biology and Medicine, Taras Shevchenko National University of Kiev

DOI:

https://doi.org/10.15407/dopovidi2018.02.102

Keywords:

C60 fullerenes, cholangitis

Abstract

The effects of water-soluble biocompatible C60 fullerenes (C60FAS) when applied intraperitoneally or per os on the liver function under rat α-naphthyl-isothiocyanate-induced cholangitis model are investigated. C60FAS when administered per os normalizes the direct bilirubin and ALT. Additionally, total bilirubin and ALP are normalized under C60FAS intraperitoneal injection, by indicating the attenuation of disease symptoms severity. Thus, the partial correction of cholangitis-induced liver failure caused by C60FAS is demonstrated, and the higher efficacy of C60FAS intraperitoneal injection is concluded.

Downloads

Download data is not yet available.

References

Skrypnyk, I. M., Melnyk, T. V. & Poiazhenko, M. M. (2007). Clinical hepatology. Poltava: Dyvosvit (in Ukrainian).

Molodecky, N. A., Kareemi, H., Parab, R., Barkema, H. W., Quan, H., Myers, R. P. & Kaplan, G. G. (2011). Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology, 53, pp. 1590-1599. doi: https://doi.org/10.1002/hep.24247

Zhu, G. Q., Shi, K. Q., Huang, G. Q., Wang, L. R., Lin, Y. Q., Braddock, M., Chen, Y. P., Zhou, M. T. & Zheng, M. H. (2015). A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. Oncotarget, 6, No. 29, pp. 26757-26769. doi: https://doi.org/10.18632/oncotarget.5610

Angulo, P., Jorgensen, R. A., Kowdley, K. V. & Lindor, K. D. (2008). Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study. Dig. Dis. Sci., 53, No. 6, pp.1716-1720. doi: https://doi.org/10.1007/s10620-007-0052-6

Prylutska, S. V., Grynyuk, I. I., Matyshevska, O. P., Prylutskyy, Yu. I., Ritter, U. & Scharff, P. (2008). Antioxidant properties of C60 fullerenes in vitro. Fullerenes, Nanotubes., Carbon Nanostruct, 16, No. 5-6, pp. 698-705. doi: https://doi.org/10.1080/15363830802317148

Kuznietsova, H. M., Dziubenko, N. V., Chereschuk, I. O. & Rybalchenko, T. V. (2017). The impact of watersoluble C60 fullerenes on the development of acute colitis in rats. Studia biologica. 11, No. 1, pp. 41-50 (in Ukrainian).

Halenova, T. I., Vareniuk, I. M., Roslova, N. M., Dzerzhynsky, M. E., Savchuk, O. M., Ostapchenko, L. I., Prylutskyy, Yu. I., Ritter, U. & Scharff, P. (2016). Hepatoprotective effect of orally applied water-soluble pristine C60 fullerene against CCl4-induced acute liver injury in rats. RSC Adv., 6, No. 102, pp. 100046-100055. doi: https://doi.org/10.1039/C6RA20291H

Lynchak, O. V., Prylutskyy, Yu. I., Rybalchenko, V. K., Kyzyma, O. A., Soloviov, D., Kostjukov, V. V., Evstigneev, M. P., Ritter, U. & Scharff, P. (2017). Comparative analysis of the antineoplastic activity of C60 fullerene with 5-fluorouracil and pyrrole derivative in vivo. Nanoscale Res. Lett., 12, No. 8, pp. 1-6. doi: https://doi.org/10.1186/s11671-016-1775-0

Prylutska, S. V., Rotko, D. M., Prylutskyy, Yu. I. & Rybalchenko, V. K. (2012). Toxicity of carbon nanostructures in in vitro and in vivo systems. Modern Problems of Toxicology, No. 3-5, pp. 49-57 (in Ukrainian).

Sumner, S. C. J., Snyder, R. W., Wingard, C., Mortensen, N. P., Holland, N. A., Shannahan, J. H., Dhungana, S., Pathmasiri, W., Han, L., Lewin, A. H. & Fennell, T. R. (2015). Distribution and biomarkers of carbon-14-labeled fullerene C60 ([14C(U)]C60) in female rats and mice for up to 30 days after intravenous exposure. J. Appl. Toxicol., 35, pp. 1452-1464. doi: https://doi.org/10.1002/jat.3110

Fickert, P., Pollheimer, M. J., Beuers, U., Lackner, C., Hirschfield, G., Housset, C., Keitel, V., Schramm, S., Marschall, H. U., Karlsen, T. H., Melum, E., Kaser, A., Eksteen, B., Strazzabosco, M., Manns, M. & Trauner, M. (2014). Characterization of animal models for primary sclerosing cholangitis (PSC). J. Hepatol., 60, pp. 1290-1303. doi: https://doi.org/10.1016/j.jhep.2014.02.006

Ritter, U., Prylutskyy, Yu. I., Evstigneev, M. P., Davidenko, N. A., Cherepanov, V. V., Senenko, A. I., Marchenko, O. A. & Naumovets, A. G. (2015). Structural features of highly stable reproducible C60 fullerene aqueous colloid solution probed by various techniques. Fullerenes, Nanotubes, Carbon Nanostruct., 23, No. 6, pp. 530-534. doi: https://doi.org/10.1080/1536383X.2013.870900

Sergijenko, V. I. & Bondareva, I. B. (2006). Mathematical statistics in slinical trials. Moscow: Geotar Me ditsina (in Russian).

Kongo, M., Sasaki, E. & Harada, N. (1999). Change in hepatic antioxidant defense system with liver injury de velopment in rats with a single alpha-naphthylisothiocyanate intoxication. Toxicology, 139, No. 3, pp. 265-275. doi: https://doi.org/10.1016/S0300-483X(99)00131-6

Takahashi, M., Kato, H., Doi, Y., Hagiwara A., Hirata-Koizumi, M., Ono, A., Kubota, R., Nishimura, T. & Hirose, A. (2012). Sub-acute oral toxicity study with fullerene C60 in rats. J. Toxicol. Sci., 37, No. 2, pp. 353-361. doi: https://doi.org/10.2131/jts.37.353

Downloads

Published

09.05.2024

How to Cite

Kuznietsova, H., Dziubenko, N., Rybalchenko, T., Ogloblya, O., & Rybalchenko, V. (2024). Correction of rat acute cholangitis using water-soluble C60 fullerene nanoparticles . Reports of the National Academy of Sciences of Ukraine, (2), 102–108. https://doi.org/10.15407/dopovidi2018.02.102

Issue

No. 2 (2018): Reports of the National Academy of Sciences of Ukraine

Section

Biology

License

Copyright (c) 2024 Reports of the National Academy of Sciences of Ukraine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)